{"id":1379,"date":"2024-10-20T21:18:02","date_gmt":"2024-10-20T21:18:02","guid":{"rendered":"https:\/\/medical-article.com\/?p=1379"},"modified":"2024-10-20T21:18:02","modified_gmt":"2024-10-20T21:18:02","slug":"employers-havent-a-clue-how-their-drug-benefits-are-managed-2","status":"publish","type":"post","link":"https:\/\/medical-article.com\/?p=1379","title":{"rendered":"\u2018Employers Haven\u2019t a Clue How Their Drug Benefits Are Managed\u2019"},"content":{"rendered":"

That is the title of a KFF article published last week<\/a>. The results are based on KFF\u2019s 2024 Employer Health Benefits Survey<\/a>. They write:<\/p>\n

For KFF\u2019s survey of 2,142 randomly selected companies, officials from those with 500 or more employees were asked how much of the rebates negotiated by [pharmacy benefit managers] PBMs returned to the company as savings. About 19% said they received most of the rebates, 27% said some, and 16% said little. Thirty-seven percent of the respondents didn\u2019t know.
While a larger percentage of officials from the largest companies said they got most or some of the rebates, the answers \u2014 and their contrast with the testimony of PBM leaders \u2014 reflect the confusion or ignorance of employers about what their drug benefit managers do, said survey leader Gary Claxton, a senior vice president at KFF, a health information nonprofit that includes KFF Health News.
\u201cI don\u2019t think they can ever know all the ways the money moves around because there are so many layers, between the wholesalers and the pharmacies and the manufacturers,\u201d he said\u2026<\/p>\n

\u201cEmployers are generally frustrated by the lack of transparency into all the prices out there,\u201d Claxton said. \u201cThey can\u2019t actually know what\u2019s true.\u201d <\/p>\n

2024 Employer Health Benefits Survey – Section 13: Employer Practices, Provider Networks, Coverage for GLP-1s, Abortion and Family Building Benefits<\/a><\/blockquote>